| pubmed-article:17615530 | rdf:type | pubmed:Citation | lld:pubmed |
| pubmed-article:17615530 | lifeskim:mentions | umls-concept:C0376358 | lld:lifeskim |
| pubmed-article:17615530 | lifeskim:mentions | umls-concept:C2348970 | lld:lifeskim |
| pubmed-article:17615530 | lifeskim:mentions | umls-concept:C1517281 | lld:lifeskim |
| pubmed-article:17615530 | pubmed:issue | 3 | lld:pubmed |
| pubmed-article:17615530 | pubmed:dateCreated | 2007-7-6 | lld:pubmed |
| pubmed-article:17615530 | pubmed:abstractText | The growing interest in high-intensity focused ultrasound (HIFU) is mainly due to its potential applications as a minimally invasive therapy. HIFU has been assessed for its role in the treatment of localized prostate cancer in patients who otherwise would not have benefited from surgery and in local recurrences after radiation failure. | lld:pubmed |
| pubmed-article:17615530 | pubmed:language | eng | lld:pubmed |
| pubmed-article:17615530 | pubmed:journal | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:17615530 | pubmed:citationSubset | IM | lld:pubmed |
| pubmed-article:17615530 | pubmed:status | MEDLINE | lld:pubmed |
| pubmed-article:17615530 | pubmed:month | Jul | lld:pubmed |
| pubmed-article:17615530 | pubmed:issn | 1073-2748 | lld:pubmed |
| pubmed-article:17615530 | pubmed:author | pubmed-author:GeletAlbertA | lld:pubmed |
| pubmed-article:17615530 | pubmed:author | pubmed-author:PoissonnierLa... | lld:pubmed |
| pubmed-article:17615530 | pubmed:author | pubmed-author:PasticierGill... | lld:pubmed |
| pubmed-article:17615530 | pubmed:author | pubmed-author:MuratFrancois... | lld:pubmed |
| pubmed-article:17615530 | pubmed:issnType | Print | lld:pubmed |
| pubmed-article:17615530 | pubmed:volume | 14 | lld:pubmed |
| pubmed-article:17615530 | pubmed:owner | NLM | lld:pubmed |
| pubmed-article:17615530 | pubmed:authorsComplete | Y | lld:pubmed |
| pubmed-article:17615530 | pubmed:pagination | 244-9 | lld:pubmed |
| pubmed-article:17615530 | pubmed:meshHeading | pubmed-meshheading:17615530... | lld:pubmed |
| pubmed-article:17615530 | pubmed:meshHeading | pubmed-meshheading:17615530... | lld:pubmed |
| pubmed-article:17615530 | pubmed:meshHeading | pubmed-meshheading:17615530... | lld:pubmed |
| pubmed-article:17615530 | pubmed:meshHeading | pubmed-meshheading:17615530... | lld:pubmed |
| pubmed-article:17615530 | pubmed:meshHeading | pubmed-meshheading:17615530... | lld:pubmed |
| pubmed-article:17615530 | pubmed:year | 2007 | lld:pubmed |
| pubmed-article:17615530 | pubmed:articleTitle | High-intensity focused ultrasound (HIFU) for prostate cancer. | lld:pubmed |
| pubmed-article:17615530 | pubmed:affiliation | Urology and Transplantation Department, Edouard Herriot Hospital, 69347 Lyon Cedex 03, France. gfj-murat@club-internet.fr | lld:pubmed |
| pubmed-article:17615530 | pubmed:publicationType | Journal Article | lld:pubmed |
| pubmed-article:17615530 | pubmed:publicationType | Review | lld:pubmed |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:17615530 | lld:pubmed |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:17615530 | lld:pubmed |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:17615530 | lld:pubmed |
